Hepamerz%25252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252520%25252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252528l-Ornithine%25252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252520l-Aspartate%25252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252520-%25252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252520lola%25252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252529

## Hepa-Merz (l-ornithine l-aspartate) ### Overview Hepa-Merz is a combination of two amino acids, L-ornithine and L-aspartate, used in the management of hyperammonemia, particularly in patients with liver dysfunction. ### Primary Indications * Treatment of latent and manifest hepatic encephalopathy. ### Adult Dosing * **Oral:** Typically, 3 sachets (each containing 6g L-ornithine L-aspartate) per day, divided into 3 doses. This equates to 18 grams of L-ornithine L-aspartate daily. Doses may be adjusted based on severity and patient response, up to a maximum of 30 grams daily. * **Intravenous (IV):** Usually administered as 5 grams (1 ampoule) infused over 30-60 minutes, twice daily. In severe cases, up to 10 grams twice daily may be used. ### Pediatric Dosing * There is **limited established pediatric dosing** for Hepa-Merz. Dosing in children should be based on clinical judgment and expert consultation, with careful monitoring. ### Dose Adjustments * No specific dose adjustments are typically required for renal impairment, but caution is advised. In hepatic impairment, the dose is guided by the degree of hyperammonemia and clinical response. ### Contraindications * Severe renal insufficiency. * Hypersensitivity to L-ornithine or L-aspartate. ### Adverse Effects * Gastrointestinal disturbances (nausea, vomiting, abdominal pain, diarrhea) are most common. * Rarely: dizziness, headache, fatigue, skin reactions. ### Key Drug Interactions * No significant drug interactions have been widely reported. ### Monitoring * Monitor ammonia levels, especially in patients with fluctuating liver function. * Assess clinical signs and symptoms of hepatic encephalopathy. * Monitor renal function, especially in patients with pre-existing kidney issues. ### Clinical Pearls * Hepa-Merz works by promoting the detoxification of ammonia in the liver (urea cycle) and in the peripheral tissues (ornithine-ketoacid transaminase pathway). * It is often used as an adjunct to other therapies for liver disease and hepatic encephalopathy. * Oral administration can be taken with or without food. Dilute sachets in sufficient liquid before administration. *** **Disclaimer:** This information is intended for clinical professionals. Always consult the most current prescribing information and local protocols before making any treatment decisions.